North Carolina Controlled Substance Prescription Requirements

To prescribe a controlled substance in North Carolina, a practitioner must hold both a federal DEA registration and (where applicable) a state Drug Control Unit registration, write the prescription with every element the law requires, transmit targeted opioid prescriptions electronically, check the state’s prescription database before writing an initial opioid and again every three months, and stay within the STOP Act’s day-supply caps for acute pain. The North Carolina controlled substance prescription requirements below walk through each of those duties in the order a prescriber encounters them.

Who Can Prescribe

Under G.S. § 90-87(22), a “practitioner” authorized to prescribe controlled substances includes physicians, dentists, optometrists, veterinarians, and other licensed individuals who dispense or administer controlled substances in the normal course of practice.¹ What each type may prescribe is not identical.

Physicians

Licensed physicians may prescribe any schedule for which they hold a valid DEA registration. The NC Medical Board notes that a DEA registration is not required to hold a medical license or prescribe non-controlled medications; it is required only for controlled substances.²

Nurse Practitioners

Nurse practitioners have prescriptive authority for Schedule II through V, but that authority runs through a Collaborative Practice Agreement with a supervising physician. The CPA lists the specific drugs and treatments the NP may prescribe and must be reviewed, signed, and dated annually by both parties.³ The NP must hold an individual DEA number that appears on every controlled substance prescription, and the supervising physician must hold at least the equivalent DEA schedule registration. For Schedule II, IIN, III, and IIIN drugs, an NP may not write more than a 30-day supply per prescription.⁴

NPs may not prescribe controlled substances for themselves, their supervising physician, immediate family members, or anyone with whom they have a sexual or significant emotional relationship. At facilities that primarily treat pain with narcotic medications, the NP must personally consult the supervising physician before prescribing a targeted controlled substance if the expected therapeutic use exceeds 30 days, with re-consultation at least every 90 days for continuous prescriptions.⁵

Physician Assistants

PAs may prescribe controlled substances if they hold a current license and comply with NC Medical Board rules. Like NPs, PAs operate under written supervisory arrangements with a physician who provides drug indications, contraindications, and a policy for periodic review of prescribed drugs. PAs practicing in a “team-based setting” under G.S. 90-9.3A are exempt from those supervision requirements and may prescribe without physician authorization.⁶ PAs must maintain a valid DEA registration; the supervising physician must hold the same schedule registration; Schedule II, IIN, III, and IIIN prescriptions are capped at a 30-day supply; and the same self, family, and supervising-physician prohibitions apply. The 30-day consultation trigger and 90-day re-consultation rule at pain-focused facilities also applies to PAs.⁷

Optometrists

Optometrists may prescribe Schedule III through V controlled substances and Schedule II hydrocodone or hydrocodone combination medications under G.S. § 90-114.⁸

Federal and State Registration

Prescribers must be registered at both the federal and state levels. State registration is handled by the North Carolina Drug Control Unit (NC-DCU) within DHHS and must be renewed annually under G.S. 90-101. The sequence matters: a practitioner must first complete NC-DCU registration and receive a state registration number before becoming eligible to register with the DEA.⁹

Individual practitioners such as physicians and dentists licensed in North Carolina are generally exempt from the separate NC-DCU registration, though they still need a DEA registration to prescribe. Facility registrations are not transferable: a change in ownership, physical location, or name requires a new registration. Any significant loss or theft of controlled substances must be reported to the local DEA office within one business day via DEA Form 106, with a copy to NC-DCU.⁹

Once licensed to prescribe or dispense controlled substances, practitioners must register for CSRS access within 30 days of obtaining or renewing that license. Failure to register can itself result in license suspension or revocation.¹⁰

What Must Appear on the Prescription

Guidance from the NC Board of Pharmacy and the NC Medical Board lists the following as required elements of a valid controlled substance prescription:¹¹

Prescriber’s full name, professional title, address, and telephone number, with the individual prescriber clearly identified in multi-provider practices.
Date of issuance, which must be the day the prescription is written.
Patient’s full legal name and address.
Drug name, strength, and dosage form.
Exact quantity prescribed.
Specific directions for use; vague phrasing such as “use as directed” should be avoided.
Authorized number of refills.
DEA number (required only for controlled substances). Both boards recommend writing it by hand rather than pre-printing it, to reduce fraud risk.
Prescriber’s legal signature and an indication of whether generic substitution is permitted.

A diagnosis or indication, the National Provider Identifier, and the days’ supply are not required by law but are considered best practices for patient education, insurance processing, and STOP Act compliance.

Electronic Prescribing of Targeted Controlled Substances

Since January 1, 2020, the STOP Act has required all targeted controlled substances — meaning Schedule II and III opioids and narcotics — to be prescribed electronically.¹² The exemptions from e-prescribing are narrow:

Practitioners other than pharmacists dispensing directly to a patient.
Orders for drugs administered in a hospital, nursing home, hospice facility, outpatient dialysis facility, or residential care facility.
Temporary technological or electrical failures, or other extenuating circumstances, provided the reason is documented in the patient’s record.
Prescriptions to be dispensed by a pharmacy on federal property, with documentation of the reason.
Licensed veterinarians, who are entirely exempt.¹³

Checking the CSRS Before You Prescribe

The North Carolina Controlled Substances Reporting System is a statewide database managed by DHHS that tracks controlled substances dispensed in outpatient settings. Since July 7, 2021, use of the CSRS has been mandatory before writing an initial prescription for a targeted controlled substance. The prescriber must review the patient’s 12-month prescription history, and for ongoing prescriptions must repeat the review every three months that the substance remains part of the patient’s care.¹⁴

For this rule, “targeted controlled substance” means Schedule II and Schedule III opioids and narcotics as listed in G.S. § 90-90(1), (2) and 90-91(d). Stimulants such as methylphenidate are not included. Prescribers do not have to keep a printed CSRS report in the chart, but they must document that the review was performed. Staff members may be registered as delegates to run queries on the prescriber’s behalf, with a separate account for each delegate.

When the CSRS Check Is Not Required

The mandatory review does not apply when controlled substances are:¹⁵

Administered in a health care setting, hospital, nursing home, outpatient dialysis facility, or residential care facility.
Prescribed for the treatment of cancer or a cancer-associated condition.
Prescribed to a patient in hospice or palliative care.

Enforcement

DHHS conducts periodic audits of prescriber compliance. A failure to use the CSRS as required may be reported to the appropriate licensing board, which can suspend or revoke the prescriber’s license.¹⁵

Day-Supply Limits on Initial Opioid Prescriptions

Effective January 1, 2018, the STOP Act imposed caps on initial prescriptions of targeted controlled substances for acute pain:¹⁶

No more than a five-day supply on initial consultation and treatment for acute pain.
No more than a seven-day supply immediately following a surgical procedure for post-operative acute pain.
After the initial prescription, a practitioner may issue any appropriate renewal, refill, or new prescription for the same pain.

The STOP Act defines “acute pain” as pain the practitioner reasonably expects to last three months or less. The caps do not apply to chronic pain, cancer care, hospice or palliative care, medication-assisted treatment for substance use disorder, or drugs wholly administered within a hospital or other specified facility.¹⁷ Practitioners who follow the supply limits are immune from civil liability and disciplinary action for doing so.

Refills, Validity, and Emergency Dispensing

Refill rules and validity periods depend on the schedule:

Schedule II: no refills permitted; the prescription must be dispensed within six months of the date written.¹⁸
Schedule III and IV: up to five refills, and the prescription expires six months from the date written, whichever limit is reached first.
Schedule V: not subject to the six-month or five-refill cap; may be refilled as authorized by the prescriber.¹⁹

Sequential Schedule II Prescriptions

Because Schedule II prescriptions cannot be refilled, federal regulations allow practitioners to issue multiple sequential prescriptions at a single office visit. Each prescription must be dated with the actual date of issuance and bear a “do not fill until” date. The total across all sequential prescriptions may not exceed a 90-day supply, and each individual prescription must still be dispensed within the state’s six-month validity window.¹⁹

Emergency Oral Prescriptions

Oral (phone-in) prescriptions are generally prohibited for Schedule II drugs. In a genuine emergency, a pharmacist may dispense a Schedule II substance on an oral order, but only in a quantity sufficient to treat the patient during the emergency period. The prescriber must then provide a written prescription within seven days, marked “Authorization for Emergency Dispensing” with the date of the oral order. If the emergency quantity is partially filled, the remainder must be dispensed within 72 hours. Schedules III through V may be dispensed on an oral prescription from a practitioner without those extra conditions.¹⁹

Telemedicine Prescribing

The NC Medical Board holds telemedicine encounters to the same standard of care as in-person visits when controlled substances are prescribed. The Board’s position statement, amended in March 2024, states that prescribing based solely on static online questionnaires is not acceptable and that practitioners must be able to ask follow-up questions and obtain adequate history. The Board notes that encounters conducted exclusively through telemedicine may not be suitable in certain situations, including pain treatment.²⁰

A federal final rule published on January 17, 2025, allows practitioners to prescribe FDA-approved Schedule III through V controlled substances for opioid use disorder via telemedicine, including audio-only encounters, without a prior in-person evaluation. Prescribers must review PDMP data for the state where the patient is located, and the initial telemedicine supply is capped at six months. The rule is a narrow exception to the in-person evaluation requirement of the Ryan Haight Online Pharmacy Consumer Protection Act.²¹

Continuing Education

Physicians must complete at least three hours of continuing medical education on controlled substance prescribing practices every three years, covering chronic pain management, recognition of abuse or misuse, or non-opioid treatment options.²² Physicians who complete the federally required training under the MATE Act are deemed in compliance with the state requirement for the relevant three-year period.

Penalties for Prescribing Violations

Criminal penalties are set primarily in G.S. § 90-95 and § 90-108. Under G.S. § 90-108, prohibited acts such as obtaining controlled substances through fraud, forgery, or misrepresentation, impersonating a practitioner, or distributing in violation of prescribing rules are generally Class 1 misdemeanors. Intentional violations are elevated to a Class I felony, and embezzlement or diversion by practitioners or authorized medical personnel involving deliberate dilution or substitution is a Class E felony.²³

Knowingly accessing or disclosing CSRS prescription information for unauthorized purposes is a Class I felony; doing so willfully for commercial advantage or to cause harm is a Class H felony and results in permanent exclusion from the reporting system.¹⁰ Alongside criminal exposure, the licensing boards can suspend or revoke prescribing privileges for compliance failures, including failure to register for or use the CSRS.

1
North Carolina General Assembly. G.S. § 90-87(22), Definition of Practitioner
2
NC Medical Board. DEA Privileges FAQ
3
NC Board of Nursing. NP Frequently Asked Questions
4
NC Medical Board. 21 NCAC 32M .0109, NP Prescriptive Authority Rules
5
North Carolina General Assembly. G.S. § 90-18.2, Nurse Practitioner Prescribing Authority
6
North Carolina General Assembly. G.S. § 90-18.1, Physician Assistant Practice Act
7
NC Medical Board. 21 NCAC 32S .0212, PA Prescribing Rules
8
National Conference of State Legislatures. Optometrists: Prescription of Controlled Substances
9
NC DHHS. NC Controlled Substances Regulatory Information
10
North Carolina General Assembly. G.S. Chapter 90, Article 5E, NC CSRS Act
11
NC Medical Board. Issuing a Valid Prescription
12
NC Medical Board. The STOP Act Summary
13
NC DHHS. SL 2017-74, Section 14: Controlled Substance Reporting for Veterinarians
14
NC Medical Board. Mandatory Use FAQs
15
Northwest AHEC. NC STOP Act Mandatory Use
16
North Carolina General Assembly. Session Law 2017-74, STOP Act
17
University of North Carolina. NC STOP Act Summary
18
North Carolina General Assembly. G.S. § 90-106, Prescriptions
19
NC Board of Pharmacy. Controlled Substance Pocket Card
20
NC Medical Board. Position Statement on Telemedicine
21
NC Medical Society. DEA, HHS Publish Final Rule on Telemedicine Prescribing for OUD
22
NC Office of Administrative Hearings. 21 NCAC 32R .0101, CME Requirements
23
North Carolina General Assembly. G.S. § 90-108, Prohibited Acts